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Available online 13 February 2009The CA1 to perirhinal cortex projection is one of multiple hippocampal–neocortical
projections considered to be involved in memory consolidation. This projection has been
shown to sustain long-term potentiation (LTP) following stimulation of CA1. Here we
examined the pharmacological properties underpinning the plasticity observed in this
projection. A stimulating electrode was inserted into the area CA1 and a recording electrode
was inserted into the perirhinal cortex of urethane-anaesthetised Wistar rats. Rats (n=6 in
each drug group) were administered with either saline (0.09%), MK-801 (NMDA antagonist;
0.1 mg/kg) or CNQX (AMPA/kainate antagonist; 1.5 mg/kg). Baseline recordings were made
for 10 min by stimulating area CA1 (0.05 Hz stimulation protocol). High-frequency
stimulation (HFS; 250 Hz) was performed and post-HFS fEPSP recordings were made for
1 h (0.05 Hz, as above). Baseline and post-HFS paired-pulse facilitation (PPF) recordings were
performed across six different interpulse intervals. CA1 and perirhinal cortex tissue samples
were taken from the stimulated and unstimulated hemispheres of each rat brain and
analysed using a brain-derived neurotrophic factor (BDNF) ELISA. Results indicate that LTP
was induced in the saline and MK-801 groups but not in the CNQX group; fEPSPs in the latter
group rapidly returned to baseline levels following a short period of post-tetanic
potentiation. Drug treatment and HFS had no effect on PPF levels. Drug treatment
significantly reduced concentrations of both CA1 and perirhinal BDNF and prevented
stimulation-induced increases in BDNF in CA1. This molecular and electrophysiological
data suggests that LTP in the CA1–perirhinal cortex projection may require activation of
postsynaptic AMPA/kainate receptors in order to sustain LTP.
© 2009 Elsevier B.V. All rights reserved.Keywords:
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The hippocampal formation is an important structure for
learning and memory (Scoville and Milner, 1957; O'Keefe and
Nadel, 1978; Squire, 1992). Although not the actual site of
storage for long-term memory, the hippocampal formation
acts as the site of association of sensory information (Rolls,(S. Commins).
er B.V. All rights reserved1996) and is required to form long-term memories. Long-term
storage is believed to occur in the neocortex with the
hippocampal formation acting in an integrative role (Squire
et al., 1984; Squire, 1992; McClelland et al., 1995; Squire and
Alvarez, 1995).
Long-term potentiation (LTP) is a phenomenon first
described in the rabbit hippocampus by Bliss and Lømo.
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mechanism, for the neurophysiological underpinnings of
memory. Two different mechanisms for the induction of LTP
have been described in the literature. The first was identified
in Schaffer collateral neurons in the hippocampus where it
was found that LTP is dependent on the N-methyl-D-aspartic
acid glutamate receptor (NMDA receptor; Collingridge et al.,
1983). The second mechanism for LTP was identified in
hippocampal mossy fibre neurons, where LTP can occur in
the absence of functional NMDA receptors (Harris and Cot-
man, 1986). This non-NMDA receptor-dependent form of LTP
has since been found to be mediated by the kainate glutamate
receptor (Castillo et al., 1997; Vignes and Collingridge, 1997;
Bortolotto et al., 1999). Kainate-induced potentiation in mossy
fibre neurons can be induced independently of the alpha-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid gluta-
mate (AMPA) receptor (Vignes and Collingridge, 1997).
A strong molecular correlate of increases in synaptic
strength, LTP and memory are the neurotrophins, a group of
proteins that include brain-derived neurotrophic factor
(BDNF), nerve growth factor (NGF), neurotrophin-3 and -4
(NT3 and NT4 respectively). BDNF (Barde et al., 1982) is a
protein that is necessary for neuronal growth in the develop-
ing brain (see Klein, 1994 for review) and also plays a role in
synaptic plasticity (Korte et al., 1995; Kang and Schuman,
1995a; 1995b; Bramham and Messaoudi, 2005; Lynch et al.,
2007). BDNF signals via its specific receptor, tropomyosin
receptor kinase B (TrkB; Squinto et al., 1991, Bramham et al.,
2008), or the low affinity neurotrophin receptor, p75 (Rodri-
guez-Tébar et al., 1990). Learning (Falkenberg et al., 1992;
Kesslak et al., 1998; 2003; Mizuno et al., 2000), exercise (Neeper
et al., 1995; 1996; Widenfalk et al., 1999) and high-frequency
stimulation of the brain (Patterson et al., 1992; Castrén et al.,
1993; Dragunow et al., 1993) all give rise to increases in BDNF
expression. For example, stimulation protocols that induce
late phase LTP are known to correlate with sustained BDNF
release, indeed, late phase LTP is impaired following disrup-
tion of BDNF-TrK interactions (Aicardi et al., 2004; Santi et al.,
2006). In addition, BDNF knockout mice show significantly
weaker LTP in area CA1 of the hippocampus compared to wild
types (Korte et al., 1995). However, deficits in LTP in BDNF
knockout mice can be reversed by the application of exogen-
ous recombinant BDNF (Korte et al., 1996; Patterson et al.,
1996). Blockade of the TrkB receptor in the hippocampus can
also impair the induction of LTP following theta-burst
stimulation (TBS) and post-tetanic blockade of the TrkB
receptor disrupts LTP maintenance (Kang et al., 1997).
Using the NMDA receptor antagonist (+)-5-methyl-10,11-
dihydro-5H-dibenzo-[a,d]cyclo-hepten-5,10-imine-maleate
(MK-801), blockade of LTP induction in dentate granule cells of
the hippocampus also blocks the concurrent increases in
BDNF expression (Dragunow et al., 1993). Application of BDNF
in the hippocampus has been shown to potentiate synaptic
transmission via the TrkB receptor, although this BDNF-
induced potentiation appears to occur independently of
NMDA receptor activation (Kang and Schuman, 1995a;
1995b). It has however also been demonstrated that BDNF
enhances phosphorylation of the hippocampal NMDA sub-
units NR1 and NR2B (Lin et al., 1998; Suen et al., 1997) in the
postsynaptic density (PSD) and that the extent of PSD NR2Bphosphorylation is similar to that of post-LTP induction sug-
gesting that BDNF may directly modulate LTP via the NMDA
receptor. Indeed, there is also evidence of BDNF interaction
with the AMPA receptor during synaptic transmission and
plasticity. Wu et al. (2004), for example, have demonstrated
that BDNF may also enhance phosphorylation of the AMPA
receptor GluR1 via changes in the NMDA receptor function
(Wu et al., 2004). While the AMPA-type glutamate receptor
modulators (the ampakines) have been shown to both
increase BDNF protein levels and attenuates the aged-related
impairment of LTP observed in hippocampal slices of
middle-aged animals (Rex et al., 2006). However, in a more
recent study examining the effects of BDNF on synaptic
transmission, Madara and Levine (2008) suggest that BDNF
does not act on postsynaptic AMPA receptors but rather it
simultaneously modulates both pre and postsynaptic NMDA
receptors.
Blocking the glutamate receptors pharmacologically have
also led to impairment in a variety of memory tasks. For
example, the NMDA receptor is implicated in both spatial
memory (Morris et al., 1986; Larkin et al., 2008) and object
recognition memory (Winters and Bussey, 2005b; de Lima et
al., 2005). Administration of AP-5 (Winters and Bussey, 2005b;
Barker et al., 2006) or MK-801 (de Lima et al., 2005; Nilsson et
al., 2007) either pre- or post-training, for example, has been
shown to impair rats' performance in object recognition tasks.
There is also evidence for the involvement of the AMPA
receptor in object recognition memory, administration of 6-
cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX) to rats
either pre- or post-training results in an impairment in
performance in an object recognition task (Winters and
Bussey, 2005b).
The perirhinal cortex is located on the dorsal and ventral
sides of the rostral region of the posterior end of the rhinal
fissure (Burwell et al., 1995; Burwell, 2000; 2001) and also seems
to play a time-dependent role in spatial learning (Nagahara et
al., 1995; Liu and Bilkey, 1998); is active with exposure to novel
environments (Liu and Bilkey, 2001); is involved in time-
dependent memory of trial specific information (Wiig and
Burwell, 1998) and may also be involved in long-termmemory
of spatial learning (Ramos, 2002; Ramos and Vaquero, 2005).
Further, the perirhinal cortex is involved in object recognition
memory (Liu and Bilkey, 2001; Winters and Bussey, 2005a;
Hannesson et al., 2005). In rats, temporary lesions of the
perirhinal cortex using lidocaine lead to deficits in object
recognition task performance (Winters and Bussey, 2005a) and
antagonism of NMDA, AMPA and kainate receptors in the
perirhinal cortex also lead to deficits in object recognition task
performance (Winters and Bussey, 2005b, Barker et al., 2006).
These studies implicate the perirhinal cortex in encoding,
retrieval and consolidation of memories, especially object
recognition memories (Winters and Bussey, 2005a; 2005b). In
addition, it seems that NMDA and kainate receptors may also
have different functional roles in object recognition memory;
with kainate receptors mediating object recognition memory
at a short but not a long delay and NMDA receptors mediating
suchmemoryat a long butnot a short delay (Barker et al., 2006).
Barker and Warburton (2008) have also demonstrated that
perirhinal NMDA receptors are required for acquisition of
short-term object-in-place associative memories.
55B R A I N R E S E A R C H 1 2 6 5 ( 2 0 0 9 ) 5 3 – 6 4Given the importance of the perirhinal cortex in various
forms of memory and that the back projections from the
hippocampus to the neocortex may participate in consolida-
tion of memories, it is important to examine these projections
in more detail. Anatomical studies utilising both anterograde
tracing (Swanson and Cowan, 1977; Van Groen and Wyss,
1990) and retrograde tracing (Deacon et al., 1983) have shown
the presence of outputs from the septal region of the area CA1
to the deep layers of the caudoventral perirhinal cortex,
completely avoiding the entorhinal cortex. The perirhinal
cortex also provides excitatory inputs to both the area CA1 and
the subiculum (Naber et al., 1999; 2001b). In addition, the
perirhinal cortex can connect with the hippocampus through
reciprocal connections with the entorhinal cortex (Burwell
and Amaral, 1998a; 1998b; Burwell, 2001) and the entorhinal
cortex is in turn reciprocally connected to the hippocampus
(Deacon et al., 1983; Kloosterman et al., 2003; Craig and
Commins, 2005; 2006).
Despite these studies there has been little work describing
either the electrophysiological or the pharmacological prop-
erties of these projections. Recently, Craig and Commins
(2005; 2006) have reported that projections from both the
area CA1 and the subiculum to the entorhinal cortex can
sustain LTP while Cousens and Otto (1998) succeeded in
inducing LTP in the CA1 to perirhinal cortex projection using
theta burst stimulation (TBS). Initial work in our lab supports
the findings of Cousens and Otto; the CA1 to perirhinal
pathway can sustain LTP for at least an hour following
250 Hz high-frequency stimulation (HFS) (Kealy and Com-
mins, unpublished observations), suggesting that the path-
way going from the area CA1 to the perirhinal cortex is
electrophysiologically active and could play a role in memory
formation.
The current study aims to extend our own preliminary
findings and those of Cousens and Otto (1998) by examining
plasticity in the CA1 to perirhinal cortex projection and also
examining the pharmacological properties of this projection
using the NMDA receptor antagonist MK-801 and the AMPA/
kainate receptor antagonist CNQX (Honoré et al., 1988).
Further, by using paired-pulse facilitation (PPF), a technique
often used to determine the locus of change following
potentiation, we wish to determine whether the potentiation
observed in the CA1 to perirhinal cortex projection is pre- or
postsynaptic in nature. Finally, given the strong role of
neurotrophins in learning and memory, especially BDNF,
changes in plasticity will be correlated with changes in BDNF
concentrations in the area CA1 and in the perirhinal cortex
using an enzyme-linked immunosorbent assay (ELISA).2. Results
An initial characterisation of the evoked response obtained
in the perirhinal cortex following a single pulse stimulation
of CA1 delivered at 0.05 Hz (n=10) revealed a mean
amplitude of −6.78 mV (±0.74), mean slope of the downward
deflection of −0.825 mV/s (±0.091) with a latency of the peak
amplitude of 8.27±0.68 ms. Although we found a significant
increase in both fEPSP peak amplitude and slope during
potentiation and facilitation (see below) we decided to limitour analyses to the slope measures consistent with the work
of Cousens and Otto (1998).
We then conducted a small set of control experiments to
examine the effect of CNQX on baseline fEPSP responses (n=3).
We recorded baseline fEPSPs for 10 min (100±0.96%) and then
injected each rat with CNQX (dose: 1.5mg/kg; concentration of
solution: 1.5 mg/ml; actual volume of injection: 1 ml/kg). We
continued to record fEPSPs for a further 3 h. fEPSP slopes
(averaged over 10 min) at 1, 2 and 3 h post-injection were
97.30±1.85%, 96.14±1.73% and 98.26±1.83% respectively. A
repeated measures ANOVA was conducted on these data
demonstrating no significant change in baseline response
over the recording period (F=1.063; df=3, 27; pN0.05).
2.1. Effects of glutamate receptor blockade on LTP
To examine the effects of glutamate blockade on LTP, a 3×4
mixed factorial ANOVA was used with time analysed on 4
levels (−10–0 min, 0–10 min, 20–30 min and 50–60 min) as a
within-groups measure. Drug treatment was analysed on 3
levels (saline, MK-801 and CNQX) as a between-groups
measure. Overall, there was a significant effect of time
(F=96.652; df=3, 81; p<0.001). Drug treatment was also
shown to have a significant effect (F=78.723; df=2, 27;
p<0.001). In addition, an interaction effect between drug
treatment and time was shown (F=13.581; df=6, 81; p<0.01).
Across the full length of the experiment (Fig. 1), saline-treated
animals showed significantly higher levels of potentiation
compared to CNQX-treated animals (p<0.001). Similarly, MK-
801-treated animals showed significantly more potentiation
compared to CNQX-treated animals (p<0.001). There was no
overall significant difference between saline-treated and MK-
801-treated animals (pN0.05).
Looking at the effects of drug treatment at different times
during recording showed some significant differences (Fig. 1).
Baseline levels (10 to 1 min pre-HFS) showed no significant
differences (pN0.05) but there were significant differences
observed between drug treatments during post-tetanic poten-
tiation (PTP; 0 to 10 min post-HFS). CNQX-treated animals
showed significantly lower levels of PTP compared to saline-
treated animals (p<0.01) and MK-801-treated animals
(p<0.001). There were no significant differences between
saline- and MK-801-treated animals (pN0.05).
Looking at middle-LTP (21 to 30 min post-HFS) in more
detail reveals that CNQX-treated animals showed significantly
lower levels of potentiation compared to saline-treated
animals (p<0.001) and MK-801-treated animals (p<0.001).
Late-LTP (51 to 60 min post-HFS) showed a further difference
between the groups. At this stage, CNQX-treated animals
again showed significantly lower levels of potentiation
compared to saline-treated animals (p<0.001) and MK-801-
treated animals (p<0.001). In addition, MK-801-treated ani-
mals also showed significantly lower levels of potentiation
compared to saline-treated animals (p<0.001).
2.2. Effects of glutamate receptor blockade on baseline and
post-HFS PPF
Prior to 250 Hz HFS, PPF recordings were made at six dif-
ferent interpulse intervals (IPI; 20 ms, 40 ms, 60 ms, 120 ms,
Fig. 1 –Effect of glutamate receptor antagonism on long-term potentiation (LTP) induced by 250 Hz high-frequency stimulation
(HFS). Saline-treated animals (n=6, black diamonds) showed LTP lasting for at least 1 h.MK-801-treated animals (n=6, dark grey
squares) showed LTP lasting approximately 50 min before beginning to deteriorate. CNQX-treated animals (n=6, light grey
triangles) showed LTP lasting only approximately 25 min before dropping below baseline levels. Each point represents an
average of three fEPSP slopes recorded over 1 min and data is expressed as a percentage of baseline fEPSP slopes where
baseline is approximately 100%. Inset are representative fEPSP traces from the three drug groups showing baseline fEPSPs
(−10 min; solid line) and post-HFS fEPSPs (+30 min; dashed line).
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drug groups (saline, MK-801 and CNQX; a between groups
measure). A 3×6×2 mixed factorial ANOVA confirmed
significant effects for interval (F=25.961; df=5, 75; p<0.001)
and for facilitation (pulse1 vs pulse2; F=60.019; df=1, 15;
p<0.001) but there were no significant effects found for drug
treatment (F=0.143; df=2, 15; pN0.05). There were no
interaction effects for interval and drug treatment (F=0.809;
df=10, 75; pN0.05) and facilitation and drug treatment
(F=0.143; df=2, 15; pN0.05) but there was an interaction
effect for interval and facilitation (F=25.961; df=5, 75;
p<0.001). The results showed that significant facilitation
occurs at shorter intervals, peaking with a 40 ms interval in
saline- and MK-801-treated animals and with a 60 ms
interval in CNQX-treated animals (Fig. 2a). Following depen-
dent t-tests, significant facilitation was found for 40 ms,
60 ms and 120 ms IPIs in all drug treatment groups (p<0.05),
for 20 ms IPI for the saline- and CNQX-treated groups
(p<0.05) and for 240 ms IPI for CNQX-treated animals alone
(p<0.05) PPF tapered out at longer intervals; there was no
significant facilitation seen in the second fEPSP response to
the second stimulus compared to the first for the 240 ms (in
saline- and MK-801-treated animals) and 480 ms intervals
(all drug treatment groups; Fig. 2a).
We then compared the percentage facilitation obtained in
each treated group and at each interval 60 min post-HFS to
the baseline facilitation levels (Fig. 2b). A 2×3×6 mixedfactorial ANOVA was employed, again with IPI as a within-
groups measure and drug treatment as a between-groups
measure and also with time (baseline and post-HFS) as a
within-groups measure. No overall effects were found for
drug treatment (F=1.608; df=1, 15; pN0.05) but significant
effects were found for time (F=7.002; df=1, 15; p<0.05) and
interval (F=28.474; df=5, 75; p<0.001). However, no interac-
tion effects were found for time and drug treatment (F=2.523;
df=2, 15; pN0.05), for interval and group (F=28.474; df=10; 75;
pN0.05) or for time and interval (F=1.586; df=5, 75; pN0.05).
Dependent t-tests revealed that there were no significant
changes observed in the saline- and CNQX-treated groups
and in the MK-801-treated group there was only a significant
attenuation in facilitation seen following HFS at the 20 ms
interval (Fig. 2b).
2.3. Effects of glutamate receptor blockade on BDNF levels
We first compared BDNF levels in the area CA1 of the
hippocampus using a 2×3 ANOVA, with hemisphere (stimu-
lated and unstimulated hemispheres) as the within-group
measure and drug treatment (saline, MK-801 and CNQX) as the
between-groups measure (Fig. 3a). There was an overall effect
for hemisphere with the area CA1 of the stimulated hemi-
sphere showing significantly higher levels of BDNF compared
to the area CA1 of the unstimulated hemisphere (F=12.787;
df=1, 15; p<0.01). We also found an overall effect for drug
Fig. 2 – (a) The effect of paired-pulse facilitation (PPF) at six interpulse intervals (IPIs) in the baseline condition. PPF peaked at
40 ms in the saline- and MK-801-treated groups and at 60 ms in the CNQX-treated group. PPF tapered off at longer intervals. (b)
Comparison between baseline and post-HFS levels of facilitation at the six IPIs. *p<0.05; **p<0.01;***p<0.001. Inset are
representative fEPSP traces recorded at the 60 ms interval for each group in the baseline (−10 min; solid line) and post-HFS
(+60 min; dashed line) conditions.
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(Tukey test) showed that the MK-801- and CNQX-treated
groups showed significantly lower levels of BDNF in the area
CA1 compared to the saline-treated group (p<0.001). Therewas also an interaction effect between drug treatment and
hemisphere in the area CA1 (F=3.564; df=2, 15; p=0.05).
Further dependent t-tests demonstrated that in the saline-
treated group there was a significant increase in BDNF levels
Fig. 3 –Effect of glutamate receptor antagonism and 250 Hz
high-frequency stimulation (HFS) on BDNF levels in (a) the
area CA1 and (b) the perirhinal cortex. Saline-treated animals
showed a significant increase in BDNF levels in the area CA1
following 250 Hz HFS. No significant increases in BDNF in the
area CA1 were found in either drug treated group. In the
perirhinal cortex there were significant increases in BDNF
levels in both the MK-801- and CNQX-treated groups but not
in the saline-treated group following HFS. There was no
significant difference between perirhinal BDNF levels in the
stimulated hemisphere in the CNQX group compared to the
saline group. *p<0.05; **p<0.01.
58 B R A I N R E S E A R C H 1 2 6 5 ( 2 0 0 9 ) 5 3 – 6 4in the stimulated side of the area CA1 compared to the
unstimulated side (t=−4.708; df=5; p<0.01). No other differ-
ences were noted.
We compared the effects of drug treatment within each
hemisphere using a one-way ANOVA. Within the area CA1 of
the unstimulated hemisphere there was a significant effect
found for drug treatment (F=87.178; df=2, 15; p<0.001). Tukey
post-hoc tests revealed that BDNF levels were significantly
higher in the saline-treated group compared to the MK-801-
and CNQX-treated groups (p<0.001 for both) and that BDNF
levels in the CNQX-treated group were significantly higher
than those in the MK-801-treated group (p<0.05). Similarly
there was an effect for drug treatment in the area CA1 of the
stimulated hemisphere (F=30.680; df=2, 15; p<0.001). Again,
Tukey post hoc tests showed that there were significantly
higher levels of BDNF in the saline-treated group compared to
the MK-801- and CNQX-treated groups (p<0.001 for both) butno significant differences betweenMK-801- and CNQX-treated
groups (pN0.05).
We next compared BDNF levels in the perirhinal cortex,
again using a 2×3 ANOVA with hemisphere (stimulated and
unstimulated hemispheres) as the within-group measure and
drug treatment (saline, MK-801 and CNQX) as the between-
groups measure (Fig. 3b). There was an overall effect for
hemisphere with the perirhinal cortex of the stimulated
hemisphere showing significantly higher levels of BDNF
compared to the perirhinal cortex of the unstimulated
(F=10.952; df=1, 15; p<0.01).
Again, an overall effect for drug treatment on BDNF levels
was observed (F=23.083; df=2, 15; p<0.001). Post-hoc analysis
(Tukey test) showed that compared to the saline-treated
group, the MK-801- and CNQX-treated groups again showed
significantly lower levels of perirhinal BDNF (p<0.001 and
p<0.01 respectively). In addition, overall BDNF levels in the
MK-801-treated group were significantly lower than the
CNQX-treated group (p<0.05). There was an interaction effect
between drug treatment and HFS in the perirhinal cortex
(F=5.036; df=2, 15; p<0.05). Dependent t-tests demonstrated
that in the MK-801 group there were significantly higher levels
in the stimulated hemisphere compared to the unstimulated
hemisphere (t=−2.762; df=5; p<0.05). A similar pattern was
observed in the CNQX-treated group (t=−3.480; df=5; p<0.05).
We again compared the effects of drug treatment within
each hemisphere using a one-way ANOVA. Within the
perirhinal cortex of the unstimulated hemisphere there was
a significant effect found for drug treatment (F=30.522; df=2,
15; p<0.001). Tukey post-hoc tests revealed that BDNF levels
were significantly higher in the saline-treated group com-
pared to the MK-801- and CNQX-treated groups (p<0.001 for
both) but no significant differences were found between the
MK-801- and the CNQX-treated groups (p<0.05). Similarly
there was an effect for drug treatment in the perirhinal cortex
of the stimulated hemisphere (F=12.055; df=2, 15; p<0.01).
Tukey post hoc tests showed that there were significantly
higher levels of BDNF in the stimulated side of the perirhinal
cortex in the saline-treated group compared to the MK-801-
treated group (p<0.01) but there were no significant differ-
ences between saline- and CNQX-treated groups (pN0.05).
However, there were significantly higher levels of perirhinal
BDNF in the stimulated hemisphere in the CNQX-treated
group compared to the MK-801-treated group (p<0.05).3. Discussion
Here we demonstrate (see also Cousens and Otto, 1998) that
the monosynaptic projection from the area CA1 to the
perirhinal cortex is capable of sustaining LTP. This finding
has important implications both in terms of memory research
and the spread of epileptiform activity generated in the
hippocampal regions. Indeed, this combined with our pre-
vious work demonstrating the capabilities of the CA1 to
entorhinal cortex and subiculum to entorhinal cortex projec-
tions of sustaining plasticity (Craig and Commins, 2005; 2006)
suggests multiple routes by which long-term memory can be
consolidated in the neocortex. As area CA1 is one of the
primary output structures of the hippocampus (VanGroen and
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Lavenex, 2007), demonstrating plasticity (short-term and long-
term) here may provide a possible route and mechanism for
information to be consolidated to long-termmemory andmay
also provide routes for temporal lobe epilepsy to spread (Paré
et al., 1992; Wozny et al., 2005).
Glutamate receptors of various kinds have been shown to
have a central role in LTP (Collingridge et al., 1983; Castillo et
al., 1997) and in memory formation (Morris et al., 1986). In the
current studies, we demonstrate that the potentiation induced
in this pathway can be blocked by CNQX and not MK-801,
perhaps suggesting that the potentiation observed in this
pathway is AMPA/kainate receptor-mediated rather than
NMDA receptor-mediated. Although it should be noted that
we observed a lowering of potentiation in the MK-801-treated
group at 50 min post-HFS, indicating that there may also be
some NMDA receptor influence at a longer time period. This
finding that NMDA and AMPA/kainate receptors may perform
different roles controlling plasticity in this projection demon-
strates the complexity of the hippocampal circuit in terms of
the types of potentiation observed in the various pathways
and may suggest different functions for the different path-
ways. For example, NMDA receptor-mediated pathways
include the Schaffer collateral (Collingridge et al., 1988, 1983),
the perforant pathway (Wu et al., 2001) and the CA1 to
subiculum pathway (Wozny et al., 2008) while kainate
receptors are known to mediate potentiation in the mossy
fibre pathway (Bortolotto et al., 1999). Bearing in mind that
CNQX is an antagonist of both AMPA and kainate receptors
(Honoré et al., 1988), we are as yet unable to say whether the
CA1 to perirhinal cortex pathway should be classed with the
mossy fibre pathway as a kainate receptor-mediated pathway
(Bortolotto et al., 1999) or as an AMPA receptor-mediated
pathway.
In addition to the type of LTP that is induced, the locus of
change following potentiation has been much debated. One
method in determining the locus of change following potentia-
tion is by comparing levels of PPF post-HFS to baseline levels of
facilitation (McNaughton, 1982; Larkman et al., 1992; Schulz et
al., 1994; Commins et al., 1998). PPF is considered to be mainly
presynaptic in nature; therefore if with potentiation there is a
change in the facilitation strength, then it is possible that this
potentiation contains at least some component of a presynaptic
mechanism (McNaughton, 1982; Larkman et al., 1992; Schulz et
al., 1994). Here we report no significant change in facilitation 1 h
post-HFS in the saline group, suggesting that the potentiation
observed in this pathway may be largely due to postsynaptic
rather than presynaptic factors (Commins et al., 1998).
We initially observed that baseline PPF remained similar
irrespective of drug treatment, suggesting that this short-term
facilitation effect is not mediated by glutamate receptors. This
would be expected as PPF is known to result from residual
calcium in the presynaptic terminal following rapid activation
of ion-gated Ca2+ channels (Wu and Saggau, 1994). Further-
more, at 60 min post-HFS we also found no significant change
in facilitation in any of the drug treated groups, again
suggesting that the potentiation observed is mainly postsy-
naptic in nature (Commins et al., 1998). Bearing this in mind,
we did observe an attenuation of the PTP response (0–10 min
post-HFS, Fig. 1) in the CNQX-treated group. PTP is also knownto be a presynaptic event where the strength of the fEPSP is
increased due to raised levels of neurotransmitter being
released (Hubbard, 1963). This attenuation of PTP in the
CNQX group suggests a small AMPA-dependent presynaptic
component to the potentiation observed in the CA1 to the
perirhinal cortex pathway.
Molecularly, saline-treated animals showed LTP and
increased BDNF levels in area CA1 in the stimulated hemi-
sphere. Although some authors demonstrate that unilateral
LTP can trigger BDNF, trkC and nerve growth factor increases
bilaterally in the hippocampal region (Bramham et al., 1996),
we cannot rule out the possibility of an increase in BDNF in the
unstimulated hemisphere in our experiment as well, we can
only suggest for now that the BDNF expression was enhanced
in the stimulated hemisphere compared to the unstimulated
side. Conversely, IP injection of either MK-801 or CNQX
reduced BDNF concentrations in both the area CA1 and the
perirhinal cortex generally. Stimulation of the hippocampal
formation has been shown inmany other studies to lead to an
increase in BDNF levels (Castrén et al., 1993; Gooney and
Lynch, 2001). It has also been shown that BDNF (Korte et al.,
1995; 1996; Patterson et al., 1996; Gooney and Lynch, 2001) and
activation of the TrkB receptor (Kang et al., 1997; Minichiello et
al., 2002) play large roles in the induction of LTP. As BDNF
production was inhibited equally in both of our drugs groups,
this suggests that glutamatergic signalling is required for
BDNF expression (Dragunow et al., 1993; Wetmore et al., 1994;
Falkenberg et al., 1996, Kesslak et al., 2003). Our findings
compare favourably with those of Dragunow et al. (1993) who
found that not only did MK-801 block the induction of LTP in
the perforant path but that it also lowered the expression of
BDNF. In addition, we found that not only did these glutamate
receptor antagonists reduce global levels of BDNF but that they
also blocked stimulation-induced increases in BDNF concen-
trations in the area CA1. This mirrors the attenuation of
learning-induced increases in BDNF expression following
administration of MK-801 in rats (Kesslak et al., 2003). This
again points to a possible necessity for glutamatergic signal-
ling in BDNF expression.
In the perirhinal cortex, where evoked responses occurred,
BDNF synthesis was also generally inhibited in both the MK-
801- and CNQX-treated groups. Interestingly, in the saline-
treated group there were no significant differences observed
between the stimulated and unstimulated hemispheres. This
may be explained by the work by Aicardi et al. (2004) where
increases in the secretion of perirhinal BDNF levels following
TBS in slices have been described. In their study, the induction
of LTP leads to an increase in BDNF secretion in the 5–12 min
following TBS (Aicardi et al., 2004); any increases in BDNF in
the perirhinal cortex of the saline group may have been
secreted by the time we took our tissue samples for analysis
(i.e. over an hour post-HFS).
Nevertheless both MK-801- and CNQX-treated groups
showed significantly higher levels of BDNF in the stimulated
hemisphere compared to the unstimulated hemisphere. Of
particular interest are the perirhinal BDNF levels in the
stimulated hemisphere of the CNQX-treated group where
they increased to a level not significantly different to those of
the saline controls (i.e. reversing the drug-induced decreases
in BDNF levels). This differs from Aicardi et al.'s experiment
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saline group, increased levels of BDNF were detected over an
hour post-HFS in our study (Figs. 3a and b) compared to an
increase lasting only 5–12 min in Aicardi et al.'s study. These
differences might be explained by the fact that Aicardi et al.
(2004) measured secreted BDNF from slices while we analysed
homogenised tissue samples and as such may have detected
unsecreted BDNF.
Overall, these findings suggest that the NMDA receptor and
the AMPA/kainate receptors not only seem to have different
functions in terms of electrophysiology in this pathway but
that these differences extend to the expression of BDNF in
these two brain areas. As some studies have shown beha-
vioural differences between NMDA receptor antagonism and
AMPA/kainate receptor antagonism (de Lima et al., 2005;
Winters and Bussey, 2005b; Nilsson et al., 2007), the electro-
physiological and molecular differences between the drug
groups are expected. Furthermore, our results demonstrating
an AMPA-mediated role in plasticity and BDNF changes
perhaps should not be too surprising given that activation
particularly of the non-NMDA receptors (AMPA and Kainate)
result in an increased expression of neurotrophic factors,
including BDNF (Zafra et al., 1990, 1992), while reciprocally
BDNF via the TrkB receptor can increase the expression levels
of AMPA receptors (Narisawa-Saito et al., 2002) which can
enhance glutamatergic transmission in hippocampal cells
(Lessmann et al., 1994; Levine et al., 1998). It is also known that
the kinetics of AMPA-mediated BDNF activation are consistent
with the known properties of AMPA receptors (Arai et al., 1996,
2002; Lockhart et al., 2007). In addition, sub-chronic adminis-
tration of CX691 (an AMPA modulator) has been shown to
elevate BDNF mRNA expression in both the whole and CA1
sub-region of the hippocampus (Woolley et al., 2009), while
administration of another AMPAmodulator (S18986) has been
shown to enhance AMPA-mediated BDNF mRNA and protein
expression in rat primary cortical neuronal cultures (Lockhart
et al., 2007). These results along with ours suggest a close
coupling of the AMPA receptor, BDNF and plasticity in the
hippocampal–perirhinal projection.
In conclusion, this study confirms the findings of Cousens
and Otto (1998) in that the projection from area CA1 to the
perirhinal cortex can undergo changes in synaptic strength
and the induction of LTP in this projection is reliant on AMPA/
kainate receptors. Moreover, from our PPF data, the changes in
plasticity appear to be mainly postsynaptic in nature. Finally,
BDNF appears to play a role in these changes in plasticity.
These factors all add weight to the idea that this back
projection may be a route for information to pass from the
hippocampus to the neocortex, a necessity for both consolida-
tion of long-termmemories and for the spread of epileptiform
activity.4. Experimental procedures
4.1. Surgery
Adult male Wistar rats (n=18; approximately 3 months old;
weight: 300–400 g; Biomedical Unit; University College Dublin)
were divided into three different groups. All animals wereanaesthetised using urethane (ethyl carbamate; 1.5 mg/kg;
Sigma; administered via intraperitoneal (IP) injection) and
mounted on a stereotaxic frame. An incision was made to
expose the skull and burr holes were made to allow the
electrodes to be inserted into the correct coordinates (Paxinos
and Watson, 2005).
A stainless bipolar stimulating electrodes (50 μmdiameter),
insulated apart from the tip, were aimed at the area CA1.
Stainless wire recording electrodes (50 μm diameter) were
aimed at the perirhinal cortex. Coordinates for both electrodes
were based on the work of Cousens and Otto (1998); the
stimulating electrode (CA1) was inserted 6.3 mm posterior to
Bregma, 5.5 mm lateral to the midline and lowered to a depth
of 2.2 mm measured from the surface of the brain. The
recording electrode (perirhinal cortex) was inserted 5.2 mm
posterior to Bregma, 4.3mm lateral to themidline and lowered
to a depth of 5.0 mm measured from the surface of the brain.
The recording electrode was inserted at an angle of 17° to
increase the chances of hitting the correct population of cells
that are part of the monosynaptic CA1 to perirhinal projection
described by Cousens and Otto (1998).
One hour pre-tetanus (Morgan and Teyler, 1999), animals in
the control group (n=6) were administered with physiological
saline (0.1 ml/100 g body weight of 0.9% NaCl; Sigma, Ireland)
and animals in the two experimental groups were given a
glutamate receptor antagonist. The first group (n=6) was
administered with MK-801 (0.1 mg/kg body weight; Sigma,
Ireland) and the second group (n=6) was administered with
CNQX (1.5 mg/kg body weight; Sigma, Ireland). All drugs were
administered via i.p. injection. All animals were given
approximately 40 min for the drug to enter their system
before running the baseline PPF protocol, which meant that
HFS could be performed approximately 1 h after drug
administration. All drugs were made up fresh each week of
the experiment and dose-sized aliquots were frozen for use
throughout the week.
4.2. Stimulation and data acquisition
Signals were filtered between 1 Hz and 1 kHz and then
amplified (DAM-50 differential amplifier, World Precision
Instruments, Hertfordshire, UK). Recordings were digitised
using a PC running Spike2 (version 5.02, CED, Cambridge, UK)
connected to a CED-1401 interface (CED, Cambridge, UK). In
analysing the field excitatory postsynaptic potentials
(fEPSPs), the slope of the response was measured (Gooney
and Lynch, 2001). The slope was calculated from the middle
two-thirds of the downward-deflecting component of the
response.
Field EPSPswere evoked by stimulatingwith a square-wave
(constant current pulse of 0.1 ms duration at a frequency of
0.05 Hz). Although both Population Spike and fEPSPs were
monitored, the incidences of the occurrence of population
spike remained low (less than 5% of cases). By means of input/
output curve determination the maximum fEPSP was found
for each individual animal. The intensity of stimulus was then
set at a level that evoked a fEPSP slope of 50–60% of the
maximum. This level is similar to that we have used before
(Craig and Commins, 2005, 2006) on the CA1 and subicular to
EC pathway and is similar to that used by other authors (Wöhrl
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pathway.
Baseline paired-pulse facilitation (PPF) effects were mea-
sured after the electrodes were allowed to settle for 10 min.
Pairs of stimuli were then delivered with various interpulse
intervals (IPIs) of 20, 40, 60, 120, 240 and 480 ms. The PPF value
was calculated by taking the value of six slopes values from
the first stimuli out of the pairs (fEPSP1) for a given IPI and
then normalising the average of six slope values from the
second stimuli from the pairs (fEPSP2) with the resulting value
expressed as a percentage (Commins et al., 1998). Following
this, baseline measurements were induced at a rate of 0.05 Hz
for another 10 min.
LTP was then induced using a high-frequency stimulation
(HFS) protocol. The HFS protocol consisted of three trains of
stimuli (each lasting 200 ms) at 250 Hz with an inter-train
interval of 30 s (Gooney et al., 2002). Following HFS, recordings
were made for an hour at 0.05 Hz. Stimulus intensity during
PPF and LTP induction was set at baseline intensity. Changes
in fEPSP slope were assessed by measuring the slope of the
response post-HFS compared to baseline response. Following
this hour of recording, post-HFS PPF recordings were made
using the same protocol as the pre-HFS PPF recordings.
4.3. BDNF ELISA
After each experiment, all animals were sacrificed by
decapitation and their brains were immediately removed.
The brains were then dissected on ice. An area of approxi-
mately 3 mm3 was removed from both area CA1 and
perirhinal cortex that contained the final resting place of
both the stimulating and recording electrode respectively.
Equivalent sized areas in the unstimulated hemisphere were
also removed for subsequent analysis. These samples were
frozen and stored in Krebs-CaCl2/dimethyl sulfoxide (DMSO)
(Krebs solution was made using pre-prepared formula; all
from Sigma, Ireland). All samples were later washed in Krebs-
CaCl2 and homogenised. 10 μl aliquots of each sample were
analysed using a Bradford protein assay in order to determine
total protein concentration. Utilising these results, the
sample solutions were normalised to be equal in concentra-
tion and an enzyme-linked immunosorbent assay (ELISA) for
BDNF was performed using a BDNF Emax® ImmunoAssay
System kit (Promega Corporation), following the manufac-
turer's protocol.
4.4. Statistical analysis
A series of dependent t-tests and mixed factorial analyses of
variance (ANOVAs) with the appropriate post-hoc test (Tukey
at the 5% level of significance) were performed using SPSS 13.0
for Windows (SPSS Software, Seattle, WA, USA). A star-rated
system was used where appropriate (⁎p<0.05; ⁎⁎p<0.01;
⁎⁎⁎p<0.001).
4.5. Ethical considerations
Laboratory procedures for the maintenance and experimenta-
tion of animals conformed to the Department of Health
(Ireland) guidelines and the European directive 86/609/EC.Every effort was made to minimise the suffering and the
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